Total Payments
$225,564
2021 Payments
$7,975
Companies
11
Transactions
62
Payment Breakdown by Category
Consulting$100,313 (44.5%)
Research$92,360 (40.9%)
Travel$18,857 (8.4%)
Other$12,930 (5.7%)
Food & Beverage$1,105 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $100,313 | 18 | 44.5% |
| Unspecified | $92,360 | 6 | 40.9% |
| Travel and Lodging | $18,857 | 18 | 8.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,930 | 2 | 5.7% |
| Food and Beverage | $1,105 | 18 | 0.5% |
Payments by Type
General
$133,204
56 transactions
Research
$92,360
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $69,712 | 20 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $46,560 | 2 | $0 (2017) |
| AngioDynamics, Inc. | $46,248 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $26,717 | 12 | $0 (2020) |
| Ethicon US, LLC | $15,750 | 3 | $0 (2017) |
| Biocompatibles UK Ltd | $9,600 | 2 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $6,100 | 1 | $0 (2021) |
| F. Hoffmann-La Roche AG | $4,077 | 3 | $0 (2019) |
| AstraZeneca UK Limited | $639.80 | 10 | $0 (2019) |
| BTG International Canada Inc. | $146.11 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $7,975 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($6,100) |
| 2020 | $12,805 | 6 | Eisai Co., Ltd. ($6,900) |
| 2019 | $14,995 | 16 | AstraZeneca Pharmaceuticals LP ($6,279) |
| 2018 | $49,573 | 11 | Eisai Inc. ($26,882) |
| 2017 | $140,216 | 27 | E.R. Squibb & Sons, L.L.C. ($46,560) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2021 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Oncology | ||||||
| 03/16/2021 | Bayer HealthCare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $6,100.00 | General |
| 12/23/2020 | Eisai Co., Ltd. | Lenvima (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: Oncology | ||||||
| 09/30/2020 | Eisai Co., Ltd. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| Category: Oncology | ||||||
| 06/18/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 06/16/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $2,700.00 | General |
| Category: Oncology | ||||||
| 03/04/2020 | AngioDynamics, Inc. | — | — | Cash or cash equivalent | $1,800.00 | Research |
| Study: ONC-205 • Category: OS | ||||||
| 01/21/2020 | AngioDynamics, Inc. | — | Travel and Lodging | In-kind items and services | $155.02 | General |
| Category: OS | ||||||
| 11/13/2019 | AngioDynamics, Inc. | — | — | Cash or cash equivalent | $4,000.00 | Research |
| Study: ONC-205 • Category: OS | ||||||
| 10/01/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $6,152.50 | General |
| Category: Oncology | ||||||
| 09/19/2019 | F. Hoffmann-La Roche AG | Avastin (Biological), TECENTRIQ | Consulting Fee | Cash or cash equivalent | $3,670.00 | General |
| Category: BioOncology | ||||||
| 09/19/2019 | F. Hoffmann-La Roche AG | Avastin (Biological), TECENTRIQ | Travel and Lodging | In-kind items and services | $310.00 | General |
| Category: BioOncology | ||||||
| 09/19/2019 | F. Hoffmann-La Roche AG | Avastin (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $96.97 | General |
| Category: BioOncology | ||||||
| 06/02/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $126.08 | General |
| 04/15/2019 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $213.70 | General |
| 04/15/2019 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $75.06 | General |
| 04/15/2019 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $37.31 | General |
| 04/15/2019 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $13.57 | General |
| 04/15/2019 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $11.30 | General |
| 04/14/2019 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $74.63 | General |
| 04/08/2019 | AstraZeneca UK Limited | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $93.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2019 | AstraZeneca UK Limited | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $79.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2019 | AstraZeneca UK Limited | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2019 | AstraZeneca UK Limited | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2018 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ONC-205 | AngioDynamics, Inc. | $45,800 | 4 |
| A Phase 1 2 Dose escalation Open label Non comparative Study of Nivolumab or Nivolumab in Combination With Ipilimumab in Advanced Hepatocellular Carcinoma Subjects With or Without Chronic Viral Hepatitis and a Randomized Open label Study of Nivolumab vs S | E.R. Squibb & Sons, L.L.C. | $38,400 | 1 |
| A Randomized Multi center Phase III Study of Nivolumab Versus Sorafenib as First Line Treatment in Patients With Advanced Hepatocellular Carcinoma CheckMate 459 CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 459 | E.R. Squibb & Sons, L.L.C. | $8,160 | 1 |
About Dr. Riccardo Lencioni, MD
Dr. Riccardo Lencioni, MD is a Diagnostic Radiology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2015. The National Provider Identifier (NPI) number assigned to this provider is 1972976579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Riccardo Lencioni, MD has received a total of $225,564 in payments from pharmaceutical and medical device companies, with $7,975 received in 2021. These payments were reported across 62 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($100,313).
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Miami, FL
- Active Since 11/04/2015
- Last Updated 11/04/2015
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1972976579
Products in Payments
- Lenvima (Drug) $69,712
- OPDIVO (Biological) $46,560
- NANOKNIFE (Device) $20,000
- CERTUS 140 MICROWAVE ABLATION SYSTEM (Device) $15,750
- LC BEAD (Device) $9,600
- IMFINZI (Drug) $9,067
- Avastin (Biological) $4,077
- THERASPHERE - BIO (Device) $146.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Miami
Mr. James Benenati, Md, MD
Diagnostic Radiology — Payments: $6.5M
Diagnostic Radiology $6.5M
Mr. George Oliveira, M.d, M.D
Diagnostic Radiology — Payments: $1.4M
Diagnostic Radiology $1.4M
Guilherme Dabus, Md, MD
Diagnostic Radiology — Payments: $509,504
Diagnostic Radiology $509,504
Mr. Barry Katzen, Md, MD
Diagnostic Radiology — Payments: $445,306
Diagnostic Radiology $445,306
Dr. Italo Linfante, M.d, M.D
Diagnostic Radiology — Payments: $284,276
Diagnostic Radiology $284,276
Dr. Juan Batlle, Md, MD
Diagnostic Radiology — Payments: $183,423
Diagnostic Radiology $183,423